MS Clinical Trial
The researchers conducting a clinical trial into the effectiveness of angioplasty in treating chronic cerebro-spinal venous insufficiency (CCSVI) and relieving the symptoms of multiple sclerosis (MS) have cancelled the trial, citing an inability to recruit enough participants in the United States.
In 2012, the Saskatchewan government committed funding to enable up to 86 Saskatchewan MS patients to participate in the clinical trial conducted by the Albany Medical Centre in Albany, New York.
About the clinical trial
A clinical trial is a set of procedures used in medical research to safely collect data about the effectiveness of a procedure, drug, device or therapy. Patients are screened before becoming involved and are carefully monitored throughout the process.
The clinical trial was a "double blind" study, meaning half of the patients would receive the procedure and half would not. Patients would not know until the study is over who actually underwent an angioplasty procedure.
Now that the clinical trial has been cancelled, participants who travelled to Albany will be informed whether or not they received angioplasty.
If you need more information about the clinical trial, call 306-787-3764.
News release, September 9, 2013.
News release, August 16, 2012.
News release, February 27, 2012.
News Release, February 7, 2012.
News Release, January 12, 2012.
Details about the MS clinical trial in Albany, New York.
Minister Don McMorris describes the process for Saskatchewan people with MS to apply to be included in the clinical trial. January 12, in Regina. (Video, 3:24)
News Release, September 23, 2011.
Find information about diagnosis and treatment of multiple sclerosis.